The current status of polycystic ovary syndrome

The importance of polycystic ovary syndrome (PCOS) has recently received mu ch publicity. Whereas previously it was thought simply to be a disorder whi ch was characterised by irregular ovulation, there is now evidence to show that it is a systemic metabolic disease determined genetically and inherite d. As well as treating the presenting problem which, for gynaecologists is usually one of irregular menstruation and anovulation, or sometimes signs o f hyperandrogenism, we believe that women should also be screened for their Lipid status and insulin resistance. Advice on behaviour modification such as increased exercise and dietary adj ustment should be recommended in addition to the treatment for ovulation in duction. In the future, the use of insulin sensitising agents may become im portant in the treatment of PCOS.